Cancer Cell Biology and Oncogenomics - John A. Copland

Home

personnel

Faculty and Staff

current projects

more pages

Quality, dedication, commitment. Mayo Clinic is highly ranked by more assessment organizations than any other major U.S. hospital or clinic

Clinical Trials

John A. Copland, Ph.D., is involved in these active clinical trials:

A Phase I/II Dose Finding Study of an Experimental New Drug CS7017, an Oral PPARγ Agonist Taken by Mouth Twice Daily in Combination With Paclitaxel Chemotherapy
Ixabepilone and Temsirolimus in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery

Appointments | Contact Us | Give to Mayo Clinic | Search

LEGAL RESTRICTIONS AND TERMS OF USE APPLICABLE TO THIS SITE

Use of this site signifies your agreement to the terms of use.
© 2013 Mayo Foundation for Medical Education and Research. All rights reserved.